Revvity 6. Mai 2026 Revvity tops Q1 estimates and unveils plans to exit China immunodiagnostics - Indian Pharma Post
Revvity 5. Mai 2026 Revvity Outperforms in Q1 2026 Driven by Pharma Rebound and Strategic Portfolio Shifts - Lab Manager
Revvity 20. Apr. 2026 A Look At Revvity (RVTY) Valuation As Mixed Recent Returns Contrast With Undervaluation Narrative - Yahoo Finance
Revvity 19. Apr. 2026 The Bull Case For Revvity (RVTY) Could Change Following Its New AI-Enabled Oncology Platform Push - simplywall.st
Revvity 17. Apr. 2026 Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026 - BioSpace
PerkinElmer 15. Apr. 2026 Former Illumination and Detection Solutions (IDS) Business Unit of PerkinElmer is now Excelitas Technologies Corp. - LEDinside
Revvity 9. Apr. 2026 Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows - Business Wire
PerkinElmer 7. Apr. 2026 PerkinElmer showcases enhanced Clarus Nova GC at analytica 2026 - Select Science
PerkinElmer 24. März 2026 PerkinElmer Unveils New Instruments to Streamline Lab Operations - Lab Manager